Market Cap 174.95M
Revenue (ttm) 32.38M
Net Income (ttm) -21.64M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -66.83%
Debt to Equity Ratio 0.00
Volume 229,500
Avg Vol 419,444
Day's Range N/A - N/A
Shares Out 97.74M
Stochastic %K 51%
Beta 1.34
Analysts Strong Sell
Price Target $4.12

Company Profile

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed t...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 314 678 6100
Address:
710 North Tucker Boulevard, Suite 110, Saint Louis, United States
zbenz
zbenz Jul. 3 at 1:58 PM
$STXS so if you think they are buyers ...isn't that a good thing? especially since they hav BOD rep
0 · Reply
Forenzi
Forenzi Jul. 3 at 3:30 AM
$STXS arbiter is one of the biggest holders !
0 · Reply
alexpitti
alexpitti Jul. 2 at 10:22 PM
happy 4th of july $STXS $DCTH $ABEO $ADBE $MIST
2 · Reply
zbenz
zbenz Jul. 2 at 12:54 PM
$STXS who's Arbiter? , can you please explain you post with a bit more detail for us newbies
2 · Reply
Forenzi
Forenzi Jun. 30 at 12:17 PM
$STXS I predict within a few days the option grantees will be selling in the open market under the usual program and Arbiter will announce they’ve bought stock . Like clockwork every year. Either put out below market bids or wait til the 2nd week in July to add on.
2 · Reply
Forenzi
Forenzi Jun. 30 at 9:50 AM
$STXS it shouldn’t take 2-3 deals for this tiny deal to close. Not like it’s going to be under scrutiny by regulators.
1 · Reply
alexpitti
alexpitti Jun. 30 at 5:44 AM
$STXS the robocath deal hasn't even closed yet. so if you didn't have the patience for that and you're already saying it was a bad deal, you have absolutely no shot of holding this until it's approved in 2-3 years and generating meaningful sales in 4-5 years
1 · Reply
brunoq14
brunoq14 Jun. 29 at 12:27 PM
$STXS No news since Q1 earnings.
1 · Reply
DecoderRing
DecoderRing Jun. 29 at 12:26 PM
$STXS It would be amazing if they can get this down below $1. Remind those who are not part of the family fund who took the shares at .35 that they have been suckered as well. Maybe that group would at least raise some alarm bells?
1 · Reply
alexpitti
alexpitti Jun. 27 at 4:02 AM
$MIST for the 9 millionth time, cardamyst does NOT compete with ablations. i would know because i have stock in $STXS which does ablations chronic meds have side effects and don't prevent all attacks. some patients suffer in silence. this fits in with patients who don't get an ablation, but still get a few attacks per year. it's not that difficult to understand
1 · Reply
Latest News on STXS
Stereotaxis management to meet with BTIG

2026-07-01T20:10:17.000Z - 2 days ago

Stereotaxis management to meet with BTIG


Stereotaxis Slides: Investor presentation

Jun 23, 2026, 7:00 AM EDT - 11 days ago

Stereotaxis Slides: Investor presentation


Stereotaxis Earnings Call Transcript: Q1 2026

May 12, 2026, 4:30 PM EDT - 7 weeks ago

Stereotaxis Earnings Call Transcript: Q1 2026


Stereotaxis Earnings release: Q1 2026

May 12, 2026, 4:30 PM EDT - 7 weeks ago

Stereotaxis Earnings release: Q1 2026


Stereotaxis Quarterly report: Q1 2026

May 12, 2026, 4:30 PM EDT - 7 weeks ago

Stereotaxis Quarterly report: Q1 2026


Stereotaxis Transcript: M&A announcement

Apr 15, 2026, 9:00 AM EDT - 2 months ago

Stereotaxis Transcript: M&A announcement


Stereotaxis Press release: M&A announcement

Apr 15, 2026, 9:00 AM EDT - 2 months ago

Stereotaxis Press release: M&A announcement


Stereotaxis to acquire Robocath, terms undisclosed

2026-04-15T11:12:19.000Z - 2 months ago

Stereotaxis to acquire Robocath, terms undisclosed


Stereotaxis Announces Definitive Agreement to Acquire Robocath

Apr 15, 2026, 7:00 AM EDT - 2 months ago

Stereotaxis Announces Definitive Agreement to Acquire Robocath


Stereotaxis receives FDA clearance for Synchrony system

2026-04-06T12:40:34.000Z - 3 months ago

Stereotaxis receives FDA clearance for Synchrony system


Stereotaxis Proxy statement: Proxy filing

Apr 3, 2026, 8:00 AM EDT - 3 months ago

Stereotaxis Proxy statement: Proxy filing


Stereotaxis Proxy statement: Proxy filing

Apr 3, 2026, 8:00 AM EDT - 3 months ago

Stereotaxis Proxy statement: Proxy filing


Stereotaxis files $100M mixed securities shelf

2026-03-13T20:30:19.000Z - 4 months ago

Stereotaxis files $100M mixed securities shelf


Stereotaxis management to meet virtually with BTIG

2026-03-13T19:35:41.000Z - 4 months ago

Stereotaxis management to meet virtually with BTIG


Stereotaxis Registration statement: Registration Filing

Mar 13, 2026, 8:00 AM EDT - 4 months ago

Stereotaxis Registration statement: Registration Filing


Stereotaxis Earnings Call Transcript: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 4 months ago

Stereotaxis Earnings Call Transcript: Q4 2025


Stereotaxis Annual report: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 4 months ago

Stereotaxis Annual report: Q4 2025


Stereotaxis Earnings release: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 4 months ago

Stereotaxis Earnings release: Q4 2025


Stereotaxis reports Q4 EPS (6c), consensus (6c)

2026-03-09T20:05:19.000Z - 4 months ago

Stereotaxis reports Q4 EPS (6c), consensus (6c)


Stereotaxis sees FY26 revenue up double digits

2026-03-09T20:05:10.000Z - 4 months ago

Stereotaxis sees FY26 revenue up double digits


Stereotaxis Reports 2025 Full Year Financial Results

Mar 9, 2026, 4:01 PM EDT - 4 months ago

Stereotaxis Reports 2025 Full Year Financial Results


Stereotaxis reports FDA approval for MAGiC Ablation Catheter

2026-01-06T13:39:16.000Z - 6 months ago

Stereotaxis reports FDA approval for MAGiC Ablation Catheter


Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter

Jan 6, 2026, 8:01 AM EST - 6 months ago

Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter


Stereotaxis initiated with an Outperform at Citizens

2025-12-16T09:40:34.000Z - 7 months ago

Stereotaxis initiated with an Outperform at Citizens


Stereotaxis Earnings Call Transcript: Q3 2025

Nov 11, 2025, 4:30 PM EST - 8 months ago

Stereotaxis Earnings Call Transcript: Q3 2025


Stereotaxis Quarterly report: Q3 2025

Nov 11, 2025, 4:30 PM EST - 8 months ago

Stereotaxis Quarterly report: Q3 2025


Stereotaxis Earnings release: Q3 2025

Nov 11, 2025, 4:30 PM EST - 8 months ago

Stereotaxis Earnings release: Q3 2025


Stereotaxis reports Q3 EPS (7c), consensus (6c)

2025-11-11T21:05:25.000Z - 8 months ago

Stereotaxis reports Q3 EPS (7c), consensus (6c)


Stereotaxis Reports 2025 Third Quarter Financial Results

Nov 11, 2025, 4:01 PM EST - 8 months ago

Stereotaxis Reports 2025 Third Quarter Financial Results


Stereotaxis announces FDA clearance for GenesisX

2025-11-10T22:01:01.000Z - 8 months ago

Stereotaxis announces FDA clearance for GenesisX


Stereotaxis resumed with a Buy at Roth Capital

2025-11-05T09:25:11.000Z - 8 months ago

Stereotaxis resumed with a Buy at Roth Capital


Stereotaxis announces completion of procedure using MAGiC Sweep

2025-09-02T12:40:31.000Z - 10 months ago

Stereotaxis announces completion of procedure using MAGiC Sweep


Stereotaxis to Present at Upcoming Investor Conferences

Sep 2, 2025, 7:51 AM EDT - 10 months ago

Stereotaxis to Present at Upcoming Investor Conferences


Stereotaxis Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 11 months ago

Stereotaxis Earnings Call Transcript: Q2 2025


Stereotaxis Quarterly report: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 11 months ago

Stereotaxis Quarterly report: Q2 2025


Stereotaxis Earnings release: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 11 months ago

Stereotaxis Earnings release: Q2 2025


Stereotaxis reports Q2 EPS (5c), consensus (6c)

2025-08-07T20:21:40.000Z - 11 months ago

Stereotaxis reports Q2 EPS (5c), consensus (6c)


Stereotaxis Reports 2025 Second Quarter Financial Results

Aug 7, 2025, 4:01 PM EDT - 11 months ago

Stereotaxis Reports 2025 Second Quarter Financial Results


Stereotaxis Earnings Call Transcript: Q1 2025

May 12, 2025, 4:30 PM EDT - 1 year ago

Stereotaxis Earnings Call Transcript: Q1 2025


Stereotaxis Quarterly report: Q1 2025

May 12, 2025, 4:30 PM EDT - 1 year ago

Stereotaxis Quarterly report: Q1 2025


Stereotaxis Earnings release: Q1 2025

May 12, 2025, 4:30 PM EDT - 1 year ago

Stereotaxis Earnings release: Q1 2025


Stereotaxis Reports 2025 First Quarter Financial Results

May 12, 2025, 4:01 PM EDT - 1 year ago

Stereotaxis Reports 2025 First Quarter Financial Results


Stereotaxis Proxy statement: Proxy Filing

Apr 4, 2025, 8:00 AM EDT - 1 year ago

Stereotaxis Proxy statement: Proxy Filing


Stereotaxis Proxy statement: Proxy Filing

Apr 4, 2025, 8:00 AM EDT - 1 year ago

Stereotaxis Proxy statement: Proxy Filing


Stereotaxis to Present at 37th Annual Roth Conference

Mar 10, 2025, 8:02 AM EDT - 1 year ago

Stereotaxis to Present at 37th Annual Roth Conference


Stereotaxis Earnings Call Transcript: Q4 2024

Mar 3, 2025, 8:30 AM EST - 1 year ago

Stereotaxis Earnings Call Transcript: Q4 2024


Stereotaxis Annual report: Q4 2024

Mar 3, 2025, 8:30 AM EST - 1 year ago

Stereotaxis Annual report: Q4 2024


Stereotaxis Earnings release: Q4 2024

Mar 3, 2025, 8:30 AM EST - 1 year ago

Stereotaxis Earnings release: Q4 2024


Stereotaxis Reports 2024 Full Year Financial Results

Mar 3, 2025, 7:30 AM EST - 1 year ago

Stereotaxis Reports 2024 Full Year Financial Results


Stereotaxis Announces First GenesisX Robotic System Order

Jan 30, 2025, 8:09 AM EST - 1 year ago

Stereotaxis Announces First GenesisX Robotic System Order


Stereotaxis Earnings Call Transcript: Q3 2024

Nov 11, 2024, 4:30 PM EST - 1 year ago

Stereotaxis Earnings Call Transcript: Q3 2024


Stereotaxis Quarterly report: Q3 2024

Nov 11, 2024, 4:30 PM EST - 1 year ago

Stereotaxis Quarterly report: Q3 2024


Stereotaxis Earnings release: Q3 2024

Nov 11, 2024, 4:30 PM EST - 1 year ago

Stereotaxis Earnings release: Q3 2024


Stereotaxis Reports 2024 Third Quarter Financial Results

Nov 11, 2024, 4:02 PM EST - 1 year ago

Stereotaxis Reports 2024 Third Quarter Financial Results


Stereotaxis Registration statement: Registration Filing

Sep 6, 2024, 8:00 AM EDT - 1 year ago

Stereotaxis Registration statement: Registration Filing


Stereotaxis Registration statement: Registration Filing

Aug 23, 2024, 8:00 AM EDT - 2 years ago

Stereotaxis Registration statement: Registration Filing


Stereotaxis Earnings Call Transcript: Q2 2024

Aug 12, 2024, 4:30 PM EDT - 2 years ago

Stereotaxis Earnings Call Transcript: Q2 2024


Stereotaxis Quarterly report: Q2 2024

Aug 12, 2024, 4:30 PM EDT - 2 years ago

Stereotaxis Quarterly report: Q2 2024


Stereotaxis Earnings release: Q2 2024

Aug 12, 2024, 4:30 PM EDT - 2 years ago

Stereotaxis Earnings release: Q2 2024


Stereotaxis Reports 2024 Second Quarter Financial Results

Aug 12, 2024, 4:05 PM EDT - 2 years ago

Stereotaxis Reports 2024 Second Quarter Financial Results


zbenz
zbenz Jul. 3 at 1:58 PM
$STXS so if you think they are buyers ...isn't that a good thing? especially since they hav BOD rep
0 · Reply
Forenzi
Forenzi Jul. 3 at 3:30 AM
$STXS arbiter is one of the biggest holders !
0 · Reply
alexpitti
alexpitti Jul. 2 at 10:22 PM
happy 4th of july $STXS $DCTH $ABEO $ADBE $MIST
2 · Reply
zbenz
zbenz Jul. 2 at 12:54 PM
$STXS who's Arbiter? , can you please explain you post with a bit more detail for us newbies
2 · Reply
Forenzi
Forenzi Jun. 30 at 12:17 PM
$STXS I predict within a few days the option grantees will be selling in the open market under the usual program and Arbiter will announce they’ve bought stock . Like clockwork every year. Either put out below market bids or wait til the 2nd week in July to add on.
2 · Reply
Forenzi
Forenzi Jun. 30 at 9:50 AM
$STXS it shouldn’t take 2-3 deals for this tiny deal to close. Not like it’s going to be under scrutiny by regulators.
1 · Reply
alexpitti
alexpitti Jun. 30 at 5:44 AM
$STXS the robocath deal hasn't even closed yet. so if you didn't have the patience for that and you're already saying it was a bad deal, you have absolutely no shot of holding this until it's approved in 2-3 years and generating meaningful sales in 4-5 years
1 · Reply
brunoq14
brunoq14 Jun. 29 at 12:27 PM
$STXS No news since Q1 earnings.
1 · Reply
DecoderRing
DecoderRing Jun. 29 at 12:26 PM
$STXS It would be amazing if they can get this down below $1. Remind those who are not part of the family fund who took the shares at .35 that they have been suckered as well. Maybe that group would at least raise some alarm bells?
1 · Reply
alexpitti
alexpitti Jun. 27 at 4:02 AM
$MIST for the 9 millionth time, cardamyst does NOT compete with ablations. i would know because i have stock in $STXS which does ablations chronic meds have side effects and don't prevent all attacks. some patients suffer in silence. this fits in with patients who don't get an ablation, but still get a few attacks per year. it's not that difficult to understand
1 · Reply
alexpitti
alexpitti Jun. 26 at 11:54 PM
$DCTH nothing is up. if you look at the volume numbers, $SI $STXS $ABEO all had way above normal volume
2 · Reply
alexpitti
alexpitti Jun. 26 at 11:45 PM
new podcast $STXS https://riverside.com/editor/preview/b7b9193a-a90a-458a-9019-df579a3f1dd2/6a32a0f1a3b303f9fea4e459?share-token=efa3b229c690be520b64&content-shared=recording-preview&utm_campaign=sharedExportedClip&utm_content=6a32a0f1a3b303f9fea4e459&skip_mobile_banner=true
0 · Reply
jacksonjohn750
jacksonjohn750 Jun. 26 at 8:00 PM
$STXS I'm telling you people. Pool your money and buy him out.. the only way this moves
0 · Reply
brunoq14
brunoq14 Jun. 26 at 7:23 PM
$STXS Tempted to add more, as things will surely improve later in the year, but my basis is already low enough.
0 · Reply
alexpitti
alexpitti Jun. 26 at 7:22 PM
david fischel set his pay package so that if the company hits $1 billion market cap by year end 2030, he gets 1 million shares. he's only getting a base salary of $60K which is very low. he has 4.5 years to get the market cap to $1 billion which is looking unlikely. so he'd just make nothing. all those adjusted expenses you see in the quarterly reports aren't actually happening. $STXS
1 · Reply
DecoderRing
DecoderRing Jun. 25 at 4:07 PM
$STXS Some days I feel like management is doing this on purpose. Suppose they have an offer at $3.50 or something (guessing) from $ABT and to avoid investor lawsuits, if they get the price down below $1 they will be able to say they were bought out at a respectable premium.
1 · Reply
S144
S144 Jun. 25 at 5:36 AM
$STXS -29% YTD - quite bad .. @alexpitti : do you see a chance for at least some recovery later this year ?
2 · Reply
DecoderRing
DecoderRing Jun. 25 at 1:34 AM
$STXS got the volume we were hoping for. Direction is the wrong way.
0 · Reply
Georges8792
Georges8792 Jun. 24 at 10:45 PM
$STXS waiting for a small recovery to sell my remaining shares. Best decision ever to get out of this crap
0 · Reply
Georges8792
Georges8792 Jun. 24 at 3:21 PM
$STXS Horrible
0 · Reply
brunoq14
brunoq14 Jun. 24 at 3:09 PM
$STXS End of quarter selling?
0 · Reply
alexpitti
alexpitti Jun. 23 at 5:53 PM
we getting smoked $STXS
1 · Reply